Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,474,849
-
Total 13F shares
-
2,163,455
-
Share change
-
+865,525
-
Total reported value
-
$3,006,983
-
Price per share
-
$1.39
-
Number of holders
-
22
-
Value change
-
+$1,189,900
-
Number of buys
-
13
-
Number of sells
-
5
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q1 2024
As of 31 Mar 2024,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,163,455 shares.
The largest 10 holders included
EPIQ Capital Group, LLC, Founders Fund V Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Founders Fund VI Management, LLC, STATE STREET CORP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.